86results about How to "Has a lethal effect" patented technology

Belonging to the field of agricultural biotechnology, the invention relates to a laodelphax striatellus lethal gene fragment. By a laboratory improved dsRNA feeding method, the invention, from laodelphax striatellus, screens out the laodelphax striatellus lethal gene fragment Ribosomal protein L9-B which can lead to laodelphax striatellus death and has sequences as shown in SEQ ID No.1. Feeding laodelphax striatellus with the dsRNA of the gene fragment provided in the invention can have good lethal effect, thus providing sequence and data bases for establishing new strategies of pest control with RNA interference technology.

The invention belongs to the field of agricultural and biological technology and relates to a Laodelphax striatellus lethal gene fragment thereof. The invention is to screen the Laodelphax striatellus lethal gene fragment Tubulin, which can lead to the death of Laodelphax striatellus after interference and has a sequence represented by SEQ ID No.1, from Laodelphax striatellus by using a laboratory improved dsRNA feeding method. When the dsRNA of the gene fragment is used for feeding Laodelphax striatellus, the maximum adjusted mortality of the Laodelphax striatellus may reach 67.4 percent, and a sequence basis and a data basis are provided for the construction of a new policy of controlling pests by using RNA interference technology.

The invention belongs to the field of agricultural and biological technology and relates to a gene silencing technique based Laodelphax striatellus lethal gene fragment Alpha1-tubulin and a dsRNA thereof. The invention is to screen the Laodelphax striatellus lethal gene fragment Alpha1-tubulin, which can lead to the death of Laodelphax striatellus after interference and has a sequence representedby SEQ ID No.1, from Laodelphax striatellus by using a laboratory improved dsRNA feeding method. When the dsRNA of the gene fragment is used for feeding Laodelphax striatellus, the adjusted mortalityof the Laodelphax striatellus may reach 70 percent, and a sequence basis and a data basis are provided for the construction of a new policy of controlling pests by using RNA interference technology.

The invention relates to a Chinese traditional medicine compound glaucescent fissistigma root capsule for curing lung cancer, liver cancer, stomach cancer and esophagus caner. Firstly volatile oil is extracted from zedoary and curcuma root, glaucescent fissistigma root is steeped in water, and solutions are extracted from the residual of zedoary and curcuma root and glaucescent fissistigma root through ethanol; the extracting solutions are mixed and filtrated to obtain a filtrate which is used to recover ethanol and is decompressed and condensed to a clear cream with a relative density of between 1.20 and 1.25 (75 DEG C); then notoginseng is crushed into fine powder and is added into the clear cream after sieving, and the fine powder and the cream are mixed evenly and dried to obtain a dried product; the volatile oil extracted from zedoary and curcuma root is sprayed onto the dried product which is crushed into fine powder and mixed evenly for encapsulation after sieving. The capsule not only has a good curative effect on lung cancer, liver cancer, stomach cancer and esophagus caner with an effectiveness ratio of above 86 percent, but also can reduce the toxic and side effect caused by radiotherapy and chemical therapy. The capsule can obviously alleviate clinical symptoms of a late cancer patient such as distress and stuffiness in the upper abdomen, ache, nausea, eructation, anorexia, bad sleep, lassitude, leucocyte reduction, ascites, bleeding, cancerous cavity, etc.